Previous 10 | Next 10 |
2023-10-03 09:39:55 ET Summary Cryoport has experienced a decline in revenue and worsening bottom line results over the past year. The company's stock has fallen 30.6% since May and 64.2% since July 2022. Despite potential in the life sciences market, Cryoport needs to show pr...
Cryoport Receives 2023 IMAPAC Asia Pacific Cell & Gene Therapy Excellence Award Cryoport Receives 2023 IMAPAC Asia Pacific Cell & Gene Therapy Excellence Award PR Newswire Company Named "Best Cell & Gene Therapy Supplier – Cryogenic Storage" NA...
2023-09-12 13:00:07 ET More on Industrial Select Sector SPDR ETF Seeking Alpha’s Quant Rating on Industrial Select Sector SPDR ETF Dividend scorecard for Industrial Select Sector SPDR ETF A Rising Interest Rate Freight Train Is Coming For The Economy X...
2023-08-17 19:25:18 ET More on CryoPort Cryoport, Inc. ( CYRX ) Q2 2023 Earnings Call Transcript Cryoport: Revising To Hold After Major Changes To Forecasts, Sentiment Cryoport: A Strong Player In Cold-Chain Logistics With Solid Growth Prospects Cryoport'...
2023-08-10 08:25:22 ET Galera Therapeutics ( GRTX ) -82% . Origin Materials ( ORGN ) -57% after Q2 earning release . Organogenesis Holdings ( ORGO ) -32% after Q2 earning release . Renovaro Biosciences ( RENB ) -23% . Wolverine World...
2023-08-09 22:42:02 ET Cryoport, Inc. (CYRX) Q2 2023 Earnings Conference Call August 9, 2023 17:00 ET Corporate Participants Todd Fromer - Investor Relations, KCSA Strategic Communications Jerrell Shelton - Chief Executive Officer Robert Stefanovich - Chief Finan...
2023-08-09 16:18:38 ET CryoPort press release ( NASDAQ: CYRX ): Q2 GAAP EPS of -$0.42 misses by $0.17 . Revenue of $57.02M (-11.2% Y/Y) beats by $0.09M . Cryoport's revenue for the full year 2023 is expected to be in the range of $233 - $243 million $233.9...
Cryoport Reports Second Quarter 2023 Financial Results PR Newswire Second quarter revenue of $57 million , in line with previously announced preliminary results Clinical trials supported by Cryoport increased to a record 668 global clinical trials by quarter end;...
Cryoport to Report Second Quarter 2023 Financial Results on August 9, 2023 PR Newswire NASHVILLE, Tenn. , Aug. 2, 2023 /PRNewswire/ -- Cry oport, Inc. (Nasdaq: CYRX) ("Cryoport" or the "Company"), a leading global provider of innovative products and s...
2023-07-28 09:00:00 ET Summary Headwaters Capital Management is an actively managed, concentrated investment strategy focused on small and mid-capitalization stocks. The portfolio gained +17.4% (17.2% net) for the second quarter of 2023 compared to a +4.8% return for the Russell M...
News, Short Squeeze, Breakout and More Instantly...
A look at the top 10 most actives in the United States GlycoMimetics Inc. (GLYC) rose 42.5% to $0.38 on volume of 73,016,681 shares NVIDIA Corporation (NVDA) rose 2.6% to $121.16 on volume of 71,818,174 shares Faraday Future Intelligent Electric Inc. (FFIE) fell 25.4% to $0.2431 on volume...
A look at the top 10 most actives in the United States NVIDIA Corporation (NVDA) fell 6.7% to $118.11 on volume of 457,565,587 shares Agrify Corporation (AGFY) rose 68.7% to $0.4251 on volume of 291,898,257 shares Ginkgo Bioworks Holdings Inc. Class A (DNA) fell 13.7% to $0.3662 on volume...
2024-06-20 20:24:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...